Patents by Inventor Wanda Coombs

Wanda Coombs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for treating shingles with N-methanocarbathymidine (N-MCT)
    Patent number: 10758536
    Abstract: The present application discloses a method of treating a Varicella-Zoster Virus (VZV) infection in an individual in need thereof, including the step of administering to said individual an effective Varicella-Zoster Virus antiviral amount of a compound called N-methanocarbathymidine (N-MCT), which has a northern configuration with the structure as follows
    Type: Grant
    Filed: May 3, 2016
    Date of Patent: September 1, 2020
    Assignee: L & J Bio Inc
    Inventors: Jennifer Moffat, Dongmei Liu, Wanda Coombs, Michael Appel, Aquilur Rahman
  • METHOD FOR TREATING SHINGLES WITH N-METHANOCARBATHYMIDINE (N-MCT)
    Publication number: 20160324857
    Abstract: The present application discloses a method of treating a Varicella-Zoster Virus (VZV) infection in an individual in need thereof, including the step of administering to said individual an effective Varicella-Zoster Virus antiviral amount of a compound called N-methanocarbathymidine (N-MCT), which has a northern configuration with the structure as follows
    Type: Application
    Filed: May 3, 2016
    Publication date: November 10, 2016
    Inventors: Jennifer MOFFAT, DONGMEI LIU, WANDA COOMBS, MICHAEL APPEL, AQUILUR RAHMAN
  • COMPOUNDS ACTING AS PEPTIDE GAP JUNCTION MODULATORS, AND USES THEREOF
    Publication number: 20120264693
    Abstract: Compounds capable of modulating intracellular gap junctional communication, as well as their use in the treatment of diseases associated with impaired gap junction intracellular communication (GJIC) 1 are disclosed.
    Type: Application
    Filed: June 11, 2010
    Publication date: October 18, 2012
    Applicants: Zealand Pharma A/S, The Regents of the University of Michigan, The Research Foundation of State Univesity of New York
    Inventors: Mario Delmar, Steven M. Taffet, Wanda Coombs, Vandana Verma, Bjarne Due Larsen
  • PEPTIDE GAP JUNCTION MODULATORS
    Publication number: 20100298225
    Abstract: Disclosed are peptides that facilitate the intercellular communication mediated by gap junctions. The invention has a wide spectrum of useful applications including use in the treatment of diseases associated with impaired gap junction intracellular communication (GJIC).
    Type: Application
    Filed: July 14, 2008
    Publication date: November 25, 2010
    Inventors: Bjarne Due Larsen, Mario Delmar, Steven M. Taffet, Wanda Coombs